Our findings are reminiscent of cytomegalovirus (CMV) reactivation being associated with worse outcomes in critically ill patients.43, 44 Analogously, EBV reactivation in nontumor cells of HIV‐positive patients with DLBCL could reflect underlying illness or immune dysfunction not reflected in standard CD4 count assessment. The gene discussed is CD4; the disease is immune system disorder.